Diagnostic Microbiology & Infectious Disease
Volume 54, Issue 1 , Pages 23-30 , January 2006

Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa

  • Dobromir N. Pavlov

      Affiliations

    • Department of Medical Virology, University of Pretoria/NHLS, PO Box 2034, Pretoria 0001, South Africa
    • Corresponding Author InformationCorresponding author.
    • ,
  • Walda B. Van Zyl

      Affiliations

    • Department of Medical Virology, University of Pretoria/NHLS, PO Box 2034, Pretoria 0001, South Africa
    • ,
  • Mariane Kruger

      Affiliations

    • Department of Paediatrics, Kalafong Hospital, Pretoria 0001, South Africa
    • ,
  • Liezl Blignaut

      Affiliations

    • Department of Paediatrics, Kalafong Hospital, Pretoria 0001, South Africa
    • ,
  • Willie O.K. Grabow

      Affiliations

    • Department of Medical Virology, University of Pretoria/NHLS, PO Box 2034, Pretoria 0001, South Africa
    • ,
  • Marthie M. Ehlers

      Affiliations

    • Department of Medical Virology, University of Pretoria/NHLS, PO Box 2034, Pretoria 0001, South Africa

Received 16 June 2005 ,Revised 21 August 2005 ,Accepted 28 August 2005.

References 

  1. Alexander JP, Gary HE, Pallansch MA. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J. Infect. Dis. 1997;175:S176–S182
  2. Bellmunt A, May G, Zell R, Pring-Akerblom P, Verhagen W, Heim A. Evolution of poliovirus Type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology. 1999;265:178–184
  3. Buttinelli G, Donati V, Fiore S, Marturano J, Plebani A, Balestri P, et al. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J. Gen. Virol. 2003;84:1215–1221
  4. Centers for Disease Control and Prevention . Prolonged poliovirus excretion in an immunodeficient person with vaccine-associated paralytic poliomyelitis. MMWR Morb. Mortal. Wkly. Rep. 1997;46:641–643
  5. Centers for Disease Control and Prevention . Progress toward poliomyelitis eradication—Southern Africa, 2001—March 2003. MMWR Morb. Mortal. Wkly. Rep. 2003;52:521–524
  6. Chitsike I, van Furth R. Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in a child with HIV infection in Zimbabwe: case report. BMJ. 1999;318:841–843
  7. Druyts-Voets E. Epidemiological features of entero non-polio isolations in Belgium 1980–1994. Epidemiol. Infect. 1997;119:71–77
  8. Egger D, Pasamontes L, Ostermayer M, Bienz K. Reverse transcription multiplex PCR for differentiation between polio- and enteroviruses from clinical and environmental samples. J. Clin. Microbiol. 1995;33:1442–1447
  9. Gow JW, Behan WMH, Clements GB, Woodall C, Riding M, Behan PO. Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. BMJ. 1991;302:692–696
  10. Hovi T, Lindholm N, Savolainen C, Stenvik M, Burns C. Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months. J. Gen. Virol. 2004;85:369–377
  11. Ion-Neldescu N, Dobrescu A, Strebel PM, Sutter RW. Vaccine-associated paralytic poliomyelitis and HIV infection. Lancet. 1994;343:51–52
  12. Kämmerer U, Kunkel B, Korn K. Nested polymerase chain reaction for specific detection of and rapid identification of human picornaviruses. J. Clin. Microbiol. 1994;32:285–291
  13. Kew OM, Sutter RW, Nottay BK, MacDonough MJ, Prevots DR, Quick L, et al. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J. Clin. Microbiol. 1998;36:2893–2899
  14. Kuan MM. Detection and rapid differentiation of human enteroviruses following genomic amplification. J. Clin. Microbiol. 1997;35:2598–2601
  15. Manor Y, Handsher R, Halmut T, Neuman M, Abramovitz B, Mates A, et al. A double-selective tissue culture system for isolation of wild-type poliovirus from sewage applied in a long term environmental surveillance. Appl. Environ. Microbiol. 1999;65:1794–1797
  16. Manor Y, Handsher R, Halmut T, Neuman M, Bobrov A, Rudich H, et al. Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority. J. Clin. Microbiol. 1999;37:1670–1675
  17. Marker Test Subcommittee, the Japan Live Poliovaccine Research Commission . Evaluation of Sabin live poliovirus vaccine in Japan, IV—Marker tests on poliovirus strains recovered from vaccinees and their contacts. Jpn. J. Med. Sci. Biol. 1967;20:167–173
  18. Melnick JL. Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In:  Fields BN,  Knipe DM,  Howley PM, et al. editor. Fields Virology. 3rd ed.. Philadelphia, PA: Lippincott-Raven; 1996;p. 655–712
  19. Minor PD. Poliovirus vaccination: current understanding of poliovirus interactions in humans and implications for the eradication of poliomyelitis. Exp. Rev. Mol. Med. 1999;http://www-ermm.cbcu.cam.ac.uk
  20. Minor PD. Biosafety consequences of eradication of wild-type polioviruses. Lancet. 2001;358:166–168
  21. Nairn C, Clements GB. A study of enterovirus isolations in Glasgow from 1977–1997. J. Med. Virol. 1999;58:304–312
  22. Shulman LM, Manor J, Handsher R, Delpeyroux F, MacDonough MJ, Halmut T, et al. Molecular and antigenic characterisation of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J. Clin. Microbiol. 2000;38:3729–3734
  23. Sutter RW, Prevots DR. Vaccine-associated paralytic poliomyelitis among immunodeficient persons. Infect. Med. 1994;11:426–438
  24. Triki H, Barbouche MR, Bahri O, Bejaoui M, Delllagi K. Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia. J. Clin. Microbiol. 2003;41:1203–1211
  25. Vivier JC, Clay CG, Grabow WOK. Detection and rapid differentiation of human enteroviruses in water sources by restriction enzyme analysis. Wat. Sci. Technol. 2001;43:209–212
  26. World Health Organization Scientific Group. Primary immunodeficiency diseases. Clin. Exp. Immunol. 1997;109:1–28
  27. Wood DJ, Sutter RW, Dowdle WR. Stopping poliovirus vaccination after eradication: issues and challenges. Bull. World Health Organ. 2000;78:347–357
  28. Wood N, Thorley B. Viewpoint towards global poliomyelitis eradication: the successes and challenges for a developed country. J. Paediatr. Child Health. 2003;39:647–650
  29. Yang C-F, De L, Holloway BP, Pallansch MA, Kew OM. Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res. 1991;20:159–179
  30. Yang C-F, De L, Yang S-J, Gòmez JR, Cruz JR, Holloway BP, et al. Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res. 1992;24:277–296
  31. Yang C-F, Naguib T, Yang S-J, Nasr E, Jorba J, Ahmed N, et al. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983–1993. J. Virol. 2003;77:8366–8377
  32. Zaoutis T, Klein JD. Enterovirus infections. Pediatr. Rev. 1998;19:183–191

PII: S0732-8893(05)00204-X

doi: 10.1016/j.diagmicrobio.2005.08.011

Diagnostic Microbiology & Infectious Disease
Volume 54, Issue 1 , Pages 23-30 , January 2006

Article Tools